Phase 4 Takayasu Arteritis Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo General Hospital477 enrolled2 locationsNCT07087912
Recruiting
Phase 4
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
Takayasu Arteritis
Shanghai Zhongshan Hospital124 enrolled1 locationNCT06498089
Recruiting
Phase 4
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
Takayasu Arteritis
Shanghai Zhongshan Hospital76 enrolled1 locationNCT05102448
Recruiting
Phase 4
A Pilot Study in Severe Patients With Takayasu Arteritis.
TreatmentTakayasu ArteritisTocilizumab+1 more
Shanghai Zhongshan Hospital40 enrolled1 locationNCT04300686